Tri-staple 2.0 Reloads; Endo GIA Reloads with Tri-Staple Technology; Endo GIA Gray Articulating Reloads; Signia Small Diameter Reloads
Covidien (Part of Medtronic) · Decision date Apr 10, 2026
What did the FDA decide?
FDA records K253657 as a 510(k) premarket notification, with a decision dated Apr 10, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Apr 10, 2026
Regulatory record facts
- Identifier
- K253657
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Covidien (Part of Medtronic)
- Product code
- GDW
- Decision code
- SESE
- Decision date
- Apr 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Staple, Implantable.
- Applicant
- Covidien (Part of Medtronic)
- Product code
- GDW
- FDA device class
- 2
FDA decision timeline
K253657 received
Application receipt date recorded by FDA.
K253657 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GDW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Tendon AnchorK263461 | Smith & Nephew, Inc. | 510(k) clearance | Oct 27, 2026 | FDA |
| Ezisurg Medical Co., Ltd. | 510(k) clearance | Sep 25, 2026 | FDA | |
| Ethicon Endo-Surgery, LLC | 510(k) clearance | May 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Covidien (Part of Medtronic)
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- North Haven, CT
Sources and methodology
- Original FDA record: K253657
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

